Efficacy observation of defibrase combined standard regimen in treatment of non ST segment elevation myocardial infarction
-
摘要: 目的 探讨应用降纤酶治疗非ST段抬高心肌梗死的临床疗效及其对预后的影响。 方法 选取住院非ST段抬高心肌梗死患者86例,随机分为对照组和治疗组,均给予规范化方案治疗,而治疗组在此基础上加用降纤酶。 结果 治疗组临床有效率明显高于对照组;心肌酶、高敏C反应蛋白水平明显低于对照组(P<0.05)。 结论 在规范治疗的基础上加用降纤酶更有利于改善患者的临床症状、减少并发症的发生,并对心肌梗死后心肌重构有一定抑制作用。
-
关键词:
- 降纤酶 /
- 急性非ST段抬高心肌梗死 /
- hs-CR
Abstract: Objective To discuss the effectiveness of defibrase in the treatment of NSTEMI and effects of defibrase on the prognosis of NSTEMI. Methods 86 patients with NSTEMI were randomly divided into treatment group and control group, patients received standard treatment, and treatment group added defibrase. Results The effective rates of the treatment group was significantly higher than control group, the level of myocardial enzymes and hs-CRP was significantly lower than control group(P<0.05). Conclusion Based on standard treatment with defibrase was more conducive to improve clinical symptoms, reduce complications, and there were some inhibitory effect on the development of myocardial remodeling after myocardial infarction. -
[1] 史继学,孔繁亭.急诊医学[M].3版.北京:中国医药科技出版社,2008:145. [2] 张象豫.药物临床信息[M].重庆:重庆出版社,2008:856. [3] Rajendran K, Devarajan N, Ganesan M, et al. Obesity, inflammation and acute myocardial infarction-expression of leptin, IL-6 and high sensitivity-CRP in chennai based population[J].Thromb J,2012,10(1):13. [4] Ghattas MH, Abo-Elmatty DM, El-Eraki AZ. C-reactive protein 1059G/C gene polymorphism, C-reactive protein levels and acute myocardial infarction[J].J Cardiovasc Med (Hagerstown), 2012,13(11):716-719.
计量
- 文章访问数: 2608
- HTML全文浏览量: 288
- PDF下载量: 88
- 被引次数: 0